{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:09:07Z","timestamp":1790820547022,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Vet Comparative Oncology"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>\n                    The DMAC protocol (dexamethasone, melphalan, actinomycin\u2010D, cytarabine) has been evaluated in American studies for the treatment of relapsed canine lymphoma, comparing similarly to other rescue protocols. The aim of this study was to evaluate efficacy and toxicity of DMAC, in a larger UK cohort of resistant canine lymphomas. Medical records of dogs with resistant non\u2010Hodgkin high\u2010grade lymphomas that received DMAC as a rescue protocol were reviewed from 2007 to 2017. Response, time from initiation to discontinuation (TTD) and toxicity (Veterinary Cooperative Oncology Group criteria) were assessed. One hundred dogs were included; 86 received CEOP (modified CHOP including epirubicin) as first\u2010line treatment. Thirty\u2010five dogs (35%) responded: 21 complete responders (CRs) and 14 partial responders (PRs). Responders had significantly longer TTD (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001) compared with non\u2010responders: 62 days (range 28\u2010952) for CR vs 32 days (range 20\u201070) for PR. Six CR received more than six cycles of DMAC (range 7\u201036 cycles) and experienced a longer TTD (median 508, range 126\u2010952 days). Thrombocytopenia occurred in 45% (24 grade 1\u20102, 21 grade 3\u20104) and neutropenia in 36% of cases (29 grade 1\u20102, 7 grade 3\u20104). Gastrointestinal toxicity occurred in 42% of dogs (40 grade 1\u20102, 2 grade 3\u20104). Owing to chemotherapy toxicity, treatment was discontinued in five, and hospitalization required in six cases. In this study, response to DMAC was lower and of generally shorter duration than previously reported. Toxicity was high, but infrequently led to hospitalization or discontinuation of treatment.\n                  <\/jats:p>","DOI":"10.1111\/vco.12457","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T01:05:39Z","timestamp":1548205539000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of a multi\u2010agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non\u2010Hodgkin high\u2010grade lymphomas: a single centre's experience"],"prefix":"10.1111","volume":"17","author":[{"given":"Katherine","family":"Smallwood","sequence":"first","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Benoit","family":"Tanis","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain A.","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Blackwood","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Killick","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-1914","authenticated-orcid":false,"given":"Isabel","family":"Amores\u2010Fuster","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-8196","authenticated-orcid":false,"given":"James","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Mas","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-2061","authenticated-orcid":false,"given":"Aaron","family":"Harper","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Marrington","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-211X","authenticated-orcid":false,"given":"Riccardo","family":"Finotello","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Science, Institute of Veterinary Science University of Liverpool, Leahurst Campus Neston UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"e_1_2_7_2_1","article-title":"The comparative diagnostic features of canine and human lymphoma","volume":"3","author":"Seelig DM","year":"2016","journal-title":"Vet Sci"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2017"},{"key":"e_1_2_7_4_1","first-page":"271","article-title":"Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma","volume":"57","author":"Wang SL","year":"2016","journal-title":"Can Vet J"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.249.9.1067"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2002.tb02411.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2006.tb01810.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.tb01959.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2011.00311.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.103456"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2010.00230.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12335"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12176"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2008.00170.x"},{"key":"e_1_2_7_15_1","first-page":"175","article-title":"The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma","volume":"55","author":"Parsons\u2010Doherty M","year":"2014","journal-title":"Can Vet J"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12387"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2006.tb00719.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2007.0005.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0357.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.239.2.209"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1939-1676.2002.tb02390.x","article-title":"MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989\u20102000)","volume":"16","author":"Rassnick KM","year":"2002","journal-title":"J Vet Intern Med"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1999.tb01452.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12055"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5810.2006.00088.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.233.3.446"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.238.4.501"},{"key":"e_1_2_7_27_1","volume-title":"Withrow & MacEwen's Small Animal Clinical Oncology","author":"Vail D","year":"2013"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.283"},{"key":"e_1_2_7_29_1","first-page":"529","volume-title":"Basic Science of Oncology","author":"Amir E","year":"2013"},{"key":"e_1_2_7_30_1","unstructured":"TherneauT. A Package for Survival Analysis in version 2.38;2015."},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2009.00200.x"},{"key":"e_1_2_7_32_1","unstructured":"ChabnerBA. Bleomycin and other antitumour antibiotics. In: Chabner BA Longo DL eds.Cancer Chemotherapy and Biotherapy. Principles and Practices. 5th ed. Philadelphia PA: Lippincott Williams & Wilkins;2011: 323\u2010341."},{"key":"e_1_2_7_33_1","volume-title":"A Surgery of Oncologists and Primary Care Clinicians, Assessing First Line Treatment of Uncomplicated Canine Lymphoma and Their Response to Some Adverse Reactions Associated with Treatment","author":"Saul C","year":"2013"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2012.00318.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvp.12008"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03237.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12356"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03224.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03247.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.5326\/JAAHA-MS-6617"},{"key":"e_1_2_7_41_1","first-page":"288","article-title":"Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog","volume":"48","author":"Page RL","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.5326\/JAAHA-MS-6020"},{"key":"e_1_2_7_43_1","first-page":"1587","article-title":"Comparison of body surface area\u2010based and weight\u2010based dosage protocols for doxorubicin administration in dogs","volume":"55","author":"Arrington KA","year":"1994","journal-title":"Am J Vet Res"}],"container-title":["Veterinary and Comparative Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvco.12457","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.12457","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vco.12457","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vco.12457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T03:53:58Z","timestamp":1720929238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vco.12457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/vco.12457"],"URL":"https:\/\/doi.org\/10.1111\/vco.12457","archive":["Portico"],"relation":{},"ISSN":["1476-5810","1476-5829"],"issn-type":[{"value":"1476-5810","type":"print"},{"value":"1476-5829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"2018-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}